NF-κB, a central proinflammatory regulator, gets activated by TNF receptor--associated factors (TRAFs). But He et al. (page 2413) now report that one TRAF family member (TRAF3) instead negatively regulates an alternative NF-κB activation pathway.

Figure 1Cells lacking TRAF3 constitutively release active p52 NF-κB.

Classical activation of NF-κB occurs by TRAF-controlled degradation of cytoplasmic inhibitory binding proteins, which leads to nuclear accumulation of the p50 forms of NF-κB. Activation can also occur by a recently discovered route requiring NF-κB--inducing kinase (NIK), which releases a different NF-κB complex, thus one containing p52.

It was known that, unlike other TRAFs, overexpression of TRAF3 does not induce the classical NF-κB pathway. By examining TRAF3-null mice (which die soon after birth), He et al. now show that cells from these mice have constitutively active noncanonical p52 NF-κB. This constitutive activation was associated with aberrant accumulation of NIK protein, but not mRNA, suggesting that TRAF3 blocks noncanonical NF-κB by reducing NIK protein stability.

Crossing the TRAF3^−/−^ mice with mice that lacked p52 prevented their early death, showing that overactivity of p52 was, indeed, the cause of lethality. The final cause of death in TRAF3^−/−^ mice is uncertain but is most likely due to over-inflammation caused by the unfettered activation of NF-κB-signaling. ![](jem_iti_end.jpg)
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